Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 4Phase 3 2Phase 4 1Phase 2/3 1

Status

Unknown 4Completed 3Recruiting 2Terminated 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 129Carcinoma, Non-Small-Cell Lung 101Prostatic Neoplasms 62Colorectal Neoplasms 49Nasopharyngeal Carcinoma 46Neoplasms 43Multiple Myeloma 41Stomach Neoplasms 34Lung Neoplasms 32Ovarian Neoplasms 31Neoplasm Metastasis 31Leukemia, Myeloid, Acute 31Carcinoma, Hepatocellular 29Squamous Cell Carcinoma of Head and Neck 27Rectal Neoplasms 27Triple Negative Breast Neoplasms 25Recurrence 25Pancreatic Neoplasms 25Small Cell Lung Carcinoma 21Esophageal Neoplasms 21Brain Neoplasms 21Uterine Cervical Neoplasms 20Colonic Neoplasms 20Lymphoma, Large B-Cell, Diffuse 18Head and Neck Neoplasms 17Urinary Bladder Neoplasms 16Leukemia, Lymphocytic, Chronic, B-Cell 16Esophageal Squamous Cell Carcinoma 16Carcinoma, Renal Cell 16Myasthenia Gravis 15

Interventions

esmolol 12-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Fibrosis × Clear all
NCT05201404 2025-04-29

LIVERATION

Can-Fite BioPharma

Phase 3 Recruiting
471 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT05769868 2024-10-01

CIBERbBECHO

Consorcio Centro de Investigación Biomédica en Red (CIBER)

Phase 3 Recruiting
1,000 enrolled

Diabetes Mellitus, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡